
Tonythetiger
837 posts



@KMIA320 @Miljenkoz ORR, C797S cohort, n=33. Everyone else was focused on first line. At EV ~ 95m, I was more interested in that intracranial cohort in experienced patients and if there's any bzz about inhibition of de novo CNS mets.

OpenAI will acquire a consulting company to contribute to a new private equity-backed joint venture to help drive adoption of its artificial intelligence software across more businesses bloomberg.com/news/articles/…












𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: After receiving a CRL for its RP1 oncolytic immunotherapy yesterday, the CEO of @Replimune walks us through the program's timeline and history, and what this might mean for its future. $REPL Full video: biotechtv.com/post/sushil-pa…










$SLNO - cantor unsure if another bidder will come forward here; on one end the valuation is on the lower side, but on the other we expect several biopharma companies have been tracking this launch closely over the last year since it took place.


JUST IN: 🇺🇸🇮🇷 United States and Iran discuss terms for a 45-day ceasefire that could lead to a permanent end to the war, Axios reports.











